Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Trulicity Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The trulicity market size has shown significant expansion over recent years. It is forecast to rise from $7.98 million in 2025 to $8.7 million in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. The past growth in this market can be linked to the increasing prevalence of type 2 diabetes, the deficiencies of oral antidiabetic drugs, the demonstrated effectiveness of glp-1 therapies, shifts in physician prescribing habits, and difficulties with patient adherence.
The trulicity market is projected to experience substantial expansion in the coming years, with its value anticipated to reach $12.15 million by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This growth throughout the forecast period can be linked to factors such as the rise in obesity-related diabetes, the broadening of GLP-1 indications, enhanced reimbursement accessibility, the escalating burden of lifestyle diseases, and wider adoption in primary care settings. Key trends during this period encompass the increasing embrace of GLP-1 receptor agonists, a transition towards once-weekly diabetes treatments, the incorporation of weight management into diabetes care, an expanded emphasis on cardiovascular risk reduction, and a growing patient inclination for the convenience offered by injectables.
Get A Free Sample Report With In-Depth Market Insights:
Trulicity Market Development Factors: What’s Supporting Demand?
The growing number of individuals with diabetes is projected to fuel the Trulicity market going forward. Diabetes is a chronic health condition characterized by elevated blood sugar levels, resulting from the body’s impaired ability to produce or effectively utilize insulin; if not properly managed, it can lead to severe complications. The expansion of the diabetes population is attributed to factors such as urbanization, unhealthy eating patterns, physical inactivity, and genetic predisposition. This rising prevalence of diabetes creates a greater demand for effective treatments like Trulicity, which helps manage blood sugar levels and improve patient outcomes. For instance, in March 2024, data from the Office for Health Improvement and Disparities, a UK-based government department, indicated that in March 2023, the percentage of people with type 1 diabetes in England receiving 8 care processes at GP practices participating in the NDA rose to 43.8%, up from 35.2% in 2022. Therefore, the increasing diabetes population is a significant driver of the Trulicity market’s growth.
Trulicity Market Segment Analysis And Revenue Potential
The trulicity market covered in this report is segmented –
1) By Type: Prefilled Syringe Package, Vial Package
2) By Application: Type 2 Diabetes Management, Glycemic Control, Weight Management, Cardiovascular Risk Reduction
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Trulicity Market Transformation Trends: What Innovations Are Driving Change?
Leading companies within the trulicity market are strategically directing investments, particularly into biologics production facilities, to secure a competitive edge and address increasing market needs. These biologics production facilities are specialized manufacturing sites intended for creating biologic drugs, which are intricate treatments sourced from living entities like monoclonal antibodies, vaccines, and cell and gene therapies. An illustrative example is Eli Lilly and Company, a US-based pharmaceutical firm, which in January 2023 committed $450 million towards expanding its manufacturing facility in North Carolina, thereby increasing the output of its diabetes medication, Trulicity. This sum supplements a previous $1.7 billion investment in the same plant, with production anticipated to commence later this year and full operational completion projected by 2027, generating an extra 100 employment opportunities. Furthermore, Lilly is establishing two new plants in Indiana and allocating €400 million for biologics manufacturing initiatives in Ireland. In total, the company intends to allocate $2.5 billion towards enhancing its manufacturing capabilities over the next few years to accommodate increasing demand and facilitate new product introductions.
Trulicity Market Key Players Shaping Industry Direction
Major companies operating in the trulicity market are Eli Lilly And Company, Novo Nordisk
View The Full Trulicity Market Report:
Trulicity Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the trulicity market in 2025. The regions covered in the trulicity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
